W Domagała

2.6k total citations
111 papers, 2.0k citations indexed

About

W Domagała is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, W Domagała has authored 111 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 26 papers in Molecular Biology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in W Domagała's work include Genetic factors in colorectal cancer (15 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Genomics and Diagnostics (9 papers). W Domagała is often cited by papers focused on Genetic factors in colorectal cancer (15 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Genomics and Diagnostics (9 papers). W Domagała collaborates with scholars based in Poland, Germany and United States. W Domagała's co-authors include Mary Osborn, K. Weber, Jan Lubiński, Maciej M. Markiewski, S Woyke, Jerzy Lasota, Paweł Domagała, Tomasz Huzarski, Maria Chosia and A Szadowska and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

W Domagała

108 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Domagała Poland 28 912 726 461 407 290 111 2.0k
P I Richman United Kingdom 27 894 1.0× 500 0.7× 296 0.6× 338 0.8× 342 1.2× 46 2.1k
Luigi Chiusa Italy 28 805 0.9× 594 0.8× 433 0.9× 335 0.8× 331 1.1× 76 2.3k
Yuesheng Jin Sweden 30 826 0.9× 1.1k 1.5× 604 1.3× 339 0.8× 340 1.2× 59 2.3k
Atsunori Oga Japan 31 929 1.0× 1.1k 1.4× 580 1.3× 410 1.0× 371 1.3× 117 2.5k
Lutz Riethdorf Germany 26 1.1k 1.2× 831 1.1× 667 1.4× 203 0.5× 213 0.7× 55 2.5k
Jan Vincents Johannessen Norway 26 524 0.6× 429 0.6× 161 0.3× 333 0.8× 272 0.9× 93 2.0k
Nanette J. Liégeois United States 22 1.7k 1.8× 1.8k 2.4× 343 0.7× 169 0.4× 189 0.7× 33 3.1k
K Hou-Jensen Denmark 32 1.4k 1.5× 927 1.3× 324 0.7× 873 2.1× 325 1.1× 87 3.4k
Benjaporn Chaiwun Thailand 23 823 0.9× 626 0.9× 823 1.8× 828 2.0× 416 1.4× 68 2.6k
M. Drijkoningen Belgium 23 786 0.9× 410 0.6× 445 1.0× 161 0.4× 196 0.7× 56 1.6k

Countries citing papers authored by W Domagała

Since Specialization
Citations

This map shows the geographic impact of W Domagała's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Domagała with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Domagała more than expected).

Fields of papers citing papers by W Domagała

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Domagała. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Domagała. The network helps show where W Domagała may publish in the future.

Co-authorship network of co-authors of W Domagała

This figure shows the co-authorship network connecting the top 25 collaborators of W Domagała. A scholar is included among the top collaborators of W Domagała based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Domagała. W Domagała is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Dariusz Bielicki, Krzysztof Safranow, & W Domagała. (2013). Thymidylate synthase expression and p21WAF1/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy. Cellular Oncology. 37(1). 17–28. 9 indexed citations
2.
Domagała, Paweł, Jolanta Hybiak, Violetta Sulżyc‐Bielicka, et al.. (2012). KRAS mutation testing in colorectal cancer as an example of the pathologist’s role in personalized targeted therapy: a practical approach. Polish Journal of Pathology. 3(3). 145–164. 30 indexed citations
3.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Elżbieta Urasińska, et al.. (2011). Expression of p21WAF1 in Astler–Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(4). 431–438. 4 indexed citations
4.
Domagała, Paweł, Dominika Wokołorczyk, Cezary Cybulski, et al.. (2011). Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer. Breast Cancer Research and Treatment. 132(3). 937–945. 30 indexed citations
5.
Domagała, Paweł, Tomasz Huzarski, Jan Lubiński, K Gugała, & W Domagała. (2010). Immunophenotypic predictive profiling of BRCA1-associated breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(1). 55–64. 23 indexed citations
6.
Sulżyc‐Bielicka, Violetta, Paweł Domagała, Maria Chosia, et al.. (2009). Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 454(6). 695–702. 7 indexed citations
7.
Urasińska, Elżbieta, et al.. (2008). In vitro assessment of adhesion molecules expression by human endothelial cells cocultured with c-erbB2-positive and c-erbB2-negative breast carcinoma cell lines.. PubMed. 59(1). 49–54. 3 indexed citations
8.
Domagała, W. (2007). Molekularne podstawy karcynogenezy i ścieżki sygnałowe niektórych nowotworów ośrodkowego układu nerwowego. Via Medica Journals. 3(3). 127–141. 3 indexed citations
9.
Chosia, Maria & W Domagała. (2003). West-Pomeranian program of cervical cancer prevention. Results of phase onestudy. Nowotwory Journal of Oncology. 53(4). 409–409. 1 indexed citations
10.
Baśkiewicz‐Masiuk, Magdalena, Marek Masiuk, W Domagała, & Bogusław Machaliński. (2002). The role of STAT5 proteins in the regulation of normal hematopoiesis. Cellular & Molecular Biology Letters. 7. 1 indexed citations
11.
Chosia, Maria, Elżbieta Bedner, & W Domagała. (2001). Can cytology sereening reduce mortality due to cervical cancer in Poland. Nowotwory Journal of Oncology. 51(5). 523–523. 1 indexed citations
12.
Domagała, W, Markus Welcker, Maria Chosia, et al.. (2001). p21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 years. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 439(2). 132–140. 28 indexed citations
13.
Dębniak, Tadeusz, Grzegorz Kurzawski, Bohdan Górski, et al.. (2000). Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. European Journal of Cancer. 36(1). 49–54. 86 indexed citations
14.
Hadaczek, Piotr, Zurab Siprashvili, Maciej M. Markiewski, et al.. (1998). Absence or reduction of Fhit expression in most clear cell renal carcinomas.. PubMed. 58(14). 2946–51. 69 indexed citations
15.
Starzyñska, Teresa, Maciej M. Markiewski, W Domagała, et al.. (1996). The clinical significance of p53 accumulation in gastric carcinoma. Cancer. 77(10). 2005–2012. 4 indexed citations
16.
Starzyñska, Teresa, Maciej M. Markiewski, W Domagała, et al.. (1996). The clinical significance of p53 accumulation in gastric carcinoma. Cancer. 77(10). 2005–2012. 39 indexed citations
17.
Gorczyca, Wojciech, Maciej M. Markiewski, Andrzej Kram, T. Tuziak, & W Domagała. (1995). Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 426(3). 229–33. 49 indexed citations
18.
Domagała, W, et al.. (1993). Immunohistochemical profile of invasive lobular carcinoma of the breast: Predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 423(6). 497–502. 37 indexed citations
19.
20.
Domagała, W & Leopold G. Koss. (1979). Surface configuration of mesothelial cells in effusions. Virchows Archiv B Cell Pathology. 30(1). 231–243. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P I Richman Breakdown of academic impact, for papers by Luigi Chiusa Breakdown of academic impact, for papers by Yuesheng Jin Breakdown of academic impact, for papers by Atsunori Oga Breakdown of academic impact, for papers by Lutz Riethdorf Breakdown of academic impact, for papers by Jan Vincents Johannessen Breakdown of academic impact, for papers by Nanette J. Liégeois Breakdown of academic impact, for papers by K Hou-Jensen Breakdown of academic impact, for papers by Benjaporn Chaiwun Breakdown of academic impact, for papers by M. Drijkoningen
Rankless by CCL
2026